Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor

Thrombosis and Haemostasis

Volumn 80, Issue 4, 1998, Pages 585-587

  Johnson, Kirk ^a   Zaror, Isabel ^a   Bauer, Diane ^a   Choi, Yoon ^a   Creasey, Abla ^a   Innis, Michael ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; SERINE PROTEINASE INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION; SACCHAROMYCES CEREVISIAE;

APROTININ; BLOOD COAGULATION; FACTOR VIIA; FACTOR XA; HUMANS; LIPOPROTEINS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 0031786801     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-70.
2. Broze GJ Jr. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 1992; 29: 159-69.
3. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ Jr. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-4.
4. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-20.
5. Enjyoji K, Miyata T, Kamikubo Y, Kato H. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site. Biochemistry 1995; 34: 17, 5725-35.
6. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 1988; 50: 803-5.
7. Petersen JG, Meyn G, Rasmussen JS, Petersen J, Bjorn SE, Jonassen I, Christiansen L, Nordfang O. Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae. J Biol Chem 1993; 268: 13344-51.
8. Wesselschmidt R, Likert K, Girard T, Wun TC, Broze GJ Jr. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood 1992; 79: 2004-10.
9. Sprecher CA, Kisiel W, Mathewes S, Foster DC. Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent. Proc Natl Acad Sci USA 1994; 91: 3353-7.
10. Dennis MS, Lazarus RA. Kunitz domain inhibitors of tissue factor-factor VIIa. I. Potent inhibitors selected from libraries by phage display. J Biol Chem 1994; 269: 22129-36.
11. Maniatis T, Fritsch EF, Sambrook J, Ed. Molecular Cloning: A Laboratory Manual. 1982, Cold Spring Harbor Laboratory, New York.
12. Brake AJ. Alpha-factor leader-directed secretion of heterologous proteins from yeast. Meth. Enzymol 1990; 185: 408-21.
13. Barr PJ, Cousens LS, Lee-Ng CT, Medina-Selby A, Masiarz FR, Hallewell RA, Chamberlain S, Bradley J, Steimer KS, Esch F, Baird AJ. Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae. J Biol Chem 1988; 263: 16471-8.
14. Cousens LS, Shuster JR, Gallegos C, Ku L, Stempien MM, Urdea MS, Sanchez-Pescador R, Taylor A, Tekamp-Olson P. High level expression of proinsulin in the yeast, Saccharomyces cerevisiae. Gene 1987; 61: 265-75.
15. Julius D, Brake A, Blair L, Kunisawa R, Thorner J. Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-alpha-factor. Cell 1984; 37: 1075-89.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
17. Girard TJ, Broze GJ, Jr. Tissue factor pathway inhibitor meth. Enzymol 1993; 222: 195-209.
18. Dennis MS, Lazarus RA. Kunitz domain inhibitors of tissue factor-factor VIIa. II. Potent and specific inhibitors by competitive phage selection. J Biol Chem 1994; 269: 22137-44.
19. Petersen LC, Bjorn SE, Olsen OH, Nordfang O, Norris F, Norris K. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem 1996; 235: 310-16.